🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Harsh Shah

University of Utah

ORCID: 0000-0001-6054-5238

Also affiliated with Huntsman Cancer Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study”.

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3867
N/A
1.0DataRank · unranked
26 citations

Ying Huang, Amy S. Ruppert, Janek S. Walker, Daniel Canfield, Casey B. Cempre +13 more

Planning strategies in the energy sector: Integrating bayesian neural networks and uncertainty quantification in scenario analysis & optimization

Computers & Chemical Engineering(2025)10.1016/j.compchemeng.2025.109097
N/A
0.425DataRank · unranked
16 citations

Halil Iseri, Harsh Shah, Eleftherios Iakovou, Efstratios N. Pistikopoulos, Funda Iseri

The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.16642
N/A
0.330DataRank · unranked
8 citations

Krystal Lau, Xiaoliang Wang, Amy J. Davidoff, Scott F. Huntington, Omer Jamy +9 more

Survival outcomes in patients with chronic lymphocytic leukemia treated at academic centers.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7544
N/A
0DataRank · unranked
3 citations

Daniel A. Ermann, Harsh Shah, Lindsey Fitzgerald, Boyu Hu, Deborah M. Stephens +1 more

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Blood(2021)10.1182/blood.2021012888
N/A
0DataRank · unranked
95 citations

Daniel Reed, Ashley McCook, Jeremy Sen, Christian Barlow, Mary‐Kate Malecek +48 more

Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia

American Journal of Hematology(2023)10.1002/ajh.26937
N/A
0DataRank · unranked
9 citations

Daniel A. Ermann, Lindsey Fitzgerald, Harsh Shah, Boyu Hu, Deborah M. Stephens +1 more

Data from Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

(2023)10.1158/1078-0432.c.6532472
N/A
0DataRank · unranked
0 citations

Ying Huang, Amy S. Ruppert, Janek S. Walker, Daniel Canfield, Casey B. Cempre +13 more

Influence of Racial and Ethnic Identity on Overall Survival in Patients with Chronic Lymphocytic Leukemia

Research Square(2022)10.21203/rs.3.rs-2389533/v1
N/A
0DataRank · unranked
2 citations

Daniel A. Ermann, Lindsey Fitzgerald, Harsh Shah, Boyu Hu, Deborah M. Stephens +1 more

Is there a role for anti-CD20 antibodies in CLL?

Hematology(2021)10.1182/hematology.2021000234
N/A
0DataRank · unranked
7 citations

Deborah M. Stephens, Harsh Shah

Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic lymphoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7508
N/A
0DataRank · unranked
4 citations

Daniel A. Ermann, Harsh Shah, Lindsey Fitzgerald, Boyu Hu, Deborah M. Stephens +1 more